Cargando…

Network-based pharmacological study of the mechanism of kaiyuzhongyutang in the treatment of tubal fimbria obstruction

To apply a network pharmacological approach to explore the targets and possible mechanisms of Kai Yu Zhong Yu Tang (KYZYT) in the treatment of tubal fimbria obstruction. The target information of KYZYT was extracted from TCMSP and HERB database. Genes related to tubal fimbria obstruction were search...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zaihong, Liu, Xiangcheng, Wang, Shengtan, Han, Lizhen, Chen, Pian, Zhong, Tingting, Wang, Bixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592347/
https://www.ncbi.nlm.nih.gov/pubmed/36281154
http://dx.doi.org/10.1097/MD.0000000000031146
_version_ 1784814904915525632
author Li, Zaihong
Liu, Xiangcheng
Wang, Shengtan
Han, Lizhen
Chen, Pian
Zhong, Tingting
Wang, Bixia
author_facet Li, Zaihong
Liu, Xiangcheng
Wang, Shengtan
Han, Lizhen
Chen, Pian
Zhong, Tingting
Wang, Bixia
author_sort Li, Zaihong
collection PubMed
description To apply a network pharmacological approach to explore the targets and possible mechanisms of Kai Yu Zhong Yu Tang (KYZYT) in the treatment of tubal fimbria obstruction. The target information of KYZYT was extracted from TCMSP and HERB database. Genes related to tubal fimbria obstruction were searched using the GENECARD database. Target protein network maps (PPI) were drawn using string database analysis and Cytoscape 3.7.1 software. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and gene function analysis (GO) enrichment analysis were performed with the help of Perl language and biological program package in R language. To explore the multiple pharmacological mechanisms of action of KYZYT in the interventional treatment of tubal fimbria obstruction and to lay the foundation for further experimental validation. Through the collection and analysis of multiple databases, 355 biological targets of KYZYT were identified. 168 targets of tubal fimbria obstruction were obtained from disease database. The “drug-component” and “drug-target” networks of KYZYT were constructed, and the protein interaction network (PPI) of overlapping targets was analyzed to identify the key targets of the drug affecting the disease. In addition, KEGG pathway analysis and GO enrichment analysis were performed on the overlapping targets to explore the mechanism of KYZYT in the treatment of tubal fimbria obstruction. KYZYT has the characteristics of multi-component, multi-target and multi-pathway in the treatment of tubal fimbria obstruction, which provides new ideas and scientific basis for further clarification of the molecular mechanism.
format Online
Article
Text
id pubmed-9592347
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-95923472022-10-25 Network-based pharmacological study of the mechanism of kaiyuzhongyutang in the treatment of tubal fimbria obstruction Li, Zaihong Liu, Xiangcheng Wang, Shengtan Han, Lizhen Chen, Pian Zhong, Tingting Wang, Bixia Medicine (Baltimore) 5600 To apply a network pharmacological approach to explore the targets and possible mechanisms of Kai Yu Zhong Yu Tang (KYZYT) in the treatment of tubal fimbria obstruction. The target information of KYZYT was extracted from TCMSP and HERB database. Genes related to tubal fimbria obstruction were searched using the GENECARD database. Target protein network maps (PPI) were drawn using string database analysis and Cytoscape 3.7.1 software. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and gene function analysis (GO) enrichment analysis were performed with the help of Perl language and biological program package in R language. To explore the multiple pharmacological mechanisms of action of KYZYT in the interventional treatment of tubal fimbria obstruction and to lay the foundation for further experimental validation. Through the collection and analysis of multiple databases, 355 biological targets of KYZYT were identified. 168 targets of tubal fimbria obstruction were obtained from disease database. The “drug-component” and “drug-target” networks of KYZYT were constructed, and the protein interaction network (PPI) of overlapping targets was analyzed to identify the key targets of the drug affecting the disease. In addition, KEGG pathway analysis and GO enrichment analysis were performed on the overlapping targets to explore the mechanism of KYZYT in the treatment of tubal fimbria obstruction. KYZYT has the characteristics of multi-component, multi-target and multi-pathway in the treatment of tubal fimbria obstruction, which provides new ideas and scientific basis for further clarification of the molecular mechanism. Lippincott Williams & Wilkins 2022-10-21 /pmc/articles/PMC9592347/ /pubmed/36281154 http://dx.doi.org/10.1097/MD.0000000000031146 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle 5600
Li, Zaihong
Liu, Xiangcheng
Wang, Shengtan
Han, Lizhen
Chen, Pian
Zhong, Tingting
Wang, Bixia
Network-based pharmacological study of the mechanism of kaiyuzhongyutang in the treatment of tubal fimbria obstruction
title Network-based pharmacological study of the mechanism of kaiyuzhongyutang in the treatment of tubal fimbria obstruction
title_full Network-based pharmacological study of the mechanism of kaiyuzhongyutang in the treatment of tubal fimbria obstruction
title_fullStr Network-based pharmacological study of the mechanism of kaiyuzhongyutang in the treatment of tubal fimbria obstruction
title_full_unstemmed Network-based pharmacological study of the mechanism of kaiyuzhongyutang in the treatment of tubal fimbria obstruction
title_short Network-based pharmacological study of the mechanism of kaiyuzhongyutang in the treatment of tubal fimbria obstruction
title_sort network-based pharmacological study of the mechanism of kaiyuzhongyutang in the treatment of tubal fimbria obstruction
topic 5600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592347/
https://www.ncbi.nlm.nih.gov/pubmed/36281154
http://dx.doi.org/10.1097/MD.0000000000031146
work_keys_str_mv AT lizaihong networkbasedpharmacologicalstudyofthemechanismofkaiyuzhongyutanginthetreatmentoftubalfimbriaobstruction
AT liuxiangcheng networkbasedpharmacologicalstudyofthemechanismofkaiyuzhongyutanginthetreatmentoftubalfimbriaobstruction
AT wangshengtan networkbasedpharmacologicalstudyofthemechanismofkaiyuzhongyutanginthetreatmentoftubalfimbriaobstruction
AT hanlizhen networkbasedpharmacologicalstudyofthemechanismofkaiyuzhongyutanginthetreatmentoftubalfimbriaobstruction
AT chenpian networkbasedpharmacologicalstudyofthemechanismofkaiyuzhongyutanginthetreatmentoftubalfimbriaobstruction
AT zhongtingting networkbasedpharmacologicalstudyofthemechanismofkaiyuzhongyutanginthetreatmentoftubalfimbriaobstruction
AT wangbixia networkbasedpharmacologicalstudyofthemechanismofkaiyuzhongyutanginthetreatmentoftubalfimbriaobstruction